conference reporter

ESMO Congress 2021

Conference Reporter in Metastatic Prostate Cancer to Cover Key Topics Being Presented at the ESMO Congress 2021


Conference Reporter  delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter  will feature coverage of selected topics in Metastatic Prostate Cancer presented at this year’s ESMO Congress 2021.

The clinicians who were surveyed selected the following expert commentators and topics from the upcoming conference.

Community-Selected Expert Commentators: 

Michael S. Cookson, MD, MMHC, FACS

Professor and Chairman
Department of Urology
University of Oklahoma Health Sciences Center
Oklahoma City, OK

Robert Dreicer, MD, MS, MACP, FASCO

Section Head, Medical Oncology
Deputy Director, University of Virginia Comprehensive Cancer Center
Associate Director for Clinical Research
Co-Director, Paul Mellon Urologic Cancer Institute
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, VA

William K. Oh, MD

Chief Medical Science Officer, Sema4
Clinical Professor of Medicine
Division of Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
New York, NY

Community-Selected Topics: 

    Biomarker-Driven Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer
    Advanced Prostate Cancer: Novel Approaches for Distant Disease
    Clinical Trial Announcements and Studies to Follow
    Practice-Changing Radiology and Nuclear Medicine in Genitourinary Malignancies
    Genomic Testing and Predictive Biomarkers in Advanced Prostate Cancer
    Updates on Imaging-Based Patient Selection

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the European Society for Medical Oncology. 

More in Metastatic Prostate Cancer


Metastatic Prostate Cancer

Prostate-Specific Membrane Antigen–Targeted Therapies: Expert Insights

Conference Reporter by Peter R. Carroll, MD, MPH

Prostate-specific membrane antigen (PSMA) has emerged as a preeminent prostate cancer target for diagnostic imaging. Additionally, as seen at the 2...READ MORE


Metastatic Prostate Cancer

High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup

Conference Reporter by Peter R. Carroll, MD, MPH

Advancements in imaging and the identification of clinical and genomic risk factors are improving the treatment of patients with high-risk localize...READ MORE


Metastatic Prostate Cancer

Treatment Sequence in Patients With Castration-Resistant Prostate Cancer

Conference Reporter by William K. Oh, MD

Strategies to sequence and combine therapies for patients with advanced prostate cancer continue to evolve as newer treatments emerge and data from...READ MORE

More In Conference Reporter